Isomorphic Labs and MSD have formed a partnership focused on utilizing AI for cancer drug discovery. Their collaboration aims to develop novel oncology drug therapies targeting small molecules. AI
IMPACT This collaboration could accelerate the development of new cancer treatments by applying AI to drug discovery processes.
RANK_REASON Partnership between two companies for a specific application of AI.
Read on Mastodon — mastodon.social →
- Cancer
- drug discovery
- Drug Therapies and the Risk of Malignancy in Crohn's Disease: Results From the TREAT™ Registry
- Isomorphic Labs
- oncology
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →